Neonatal cholestasis / conjugated hyperbilirubinaemia (biliary atresia red flags)
Pale stool, dark urine < 60 days · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Conjugated (direct) hyperbilirubinaemia — direct bilirubin >17-25 micromol/L or >20% of total — is always pathological and defines neonatal cholestasis. The must-not-miss diagnosis is biliary atresia, where a Kasai portoenterostomy performed before ~60 days of life markedly improves outcome, so any jaundice persisting beyond 14 days (21 days if preterm) needs a split bilirubin.
Red flags
- Persistently pale/acholic stools and dark urine
- Jaundice beyond 14 days without a split bilirubin checked
- Hepatomegaly, ascites or coagulopathy
- Failure to thrive
- Age approaching 60 days without a diagnosis in suspected biliary atresia
Assessment
Differential diagnosis
- Biliary atresia
- Neonatal (idiopathic) hepatitis / infectious hepatitis
- Choledochal cyst
- Alpha-1-antitrypsin deficiency
- Galactosaemia / other metabolic disease
- TPN-associated cholestasis
- Alagille syndrome / progressive familial intrahepatic cholestasis
Investigations
- Split (conjugated and unconjugated) serum bilirubin — the key test for prolonged jaundice
- LFTs including GGT, albumin, and coagulation (PT/INR)
- Fasting/serial stool colour assessment with stool colour chart
- Liver ultrasound (absent/contracted gallbladder, triangular cord sign, choledochal cyst)
- Alpha-1-antitrypsin level/phenotype, TSH/T4, galactosaemia screen, metabolic and infection screen
- HIDA scan and/or liver biopsy and intraoperative cholangiogram where indicated
Management
- Request a split bilirubin on any infant jaundiced beyond 14 days (21 days if preterm)
- Confirm conjugated fraction and document stool and urine colour
- Check and correct coagulation — give IV vitamin K for any coagulopathy
- Send the full cholestasis panel (infective, metabolic, endocrine, genetic) without delay
- Arrange a fasting liver ultrasound reviewed by a paediatric radiologist
- Refer urgently to a paediatric hepatology/surgical centre — do not wait for all results if biliary atresia possible
- Start fat-soluble vitamin supplementation (A, D, E, K) and consider MCT-based feeds
- Treat any identified cause (e.g. remove lactose for galactosaemia, antivirals for HSV)
- Proceed to intraoperative cholangiogram and Kasai if biliary atresia confirmed, ideally before 60 days
- Monitor growth, nutrition and for progression to cirrhosis/portal hypertension
Drugs & doses
Vitamin K (phytomenadione) IV for coagulopathy (e.g. 1 mg IV, repeat per INR response)
Fat-soluble vitamin supplements A, D, E and K at cholestasis-adjusted doses
Ursodeoxycholic acid 10-20 mg/kg/day PO in divided doses (choleretic, cause-dependent)
Cause-specific therapy (e.g. IV aciclovir for HSV; lactose-free feed for galactosaemia)
Disposition
Urgent referral to specialist paediatric liver centre; admit for expedited work-up if biliary atresia suspected. Lifelong hepatology follow-up.
Complications & pitfalls
- Cirrhosis and portal hypertension
- Vitamin K-dependent bleeding
- Fat-soluble vitamin deficiency and failure to thrive
- Need for liver transplantation
- Sepsis/cholangitis after Kasai
Exam pearls
- Conjugated jaundice is NEVER physiological — always investigate
- The single highest-yield action is a split bilirubin on prolonged jaundice
- Kasai success falls sharply after ~8 weeks of age — refer early, investigate in parallel
- Pale stools + dark urine + hepatomegaly are the biliary atresia triad
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.